Effect of percutaneous ventricular assist devices on renal function

Huijuan Mao, Anna Giuliani, Lourdes Blanca-Martos, Jeong Chul Kim, Akash Nayak, Grazia Virzi, Alessandra Brocca, Elisa Scalzotto, Mauro Neri, Nevin Katz, Claudio Ronco

Research output: Contribution to journalArticlepeer-review


Ventricular assist devices (VADs) are used to improve the systemic circulation and to decrease ventricular loading in patients with hemodynamic instability that is refractory to pharmacologic therapies. During an acute critical event, percutaneous devices are preferred because of their rapid deployment, since implantable devices require more extensive procedures. Implantable devices are used for patients with established end-stage heart failure as a bridge to heart transplantation, recovery or destination therapy. This report reviews mechanical principles and clinical studies regarding percutaneous VAD to address their potential renal effects. Since the focus of this study is set on devices that are dedicated to cardiac support only, extracorporeal membrane oxygenation systems are not included.

Original languageEnglish (US)
Pages (from-to)119-126
Number of pages8
JournalBlood Purification
Issue number1-3
StatePublished - Jan 2013


  • Acute kidney injury
  • Cardiovascular disease
  • Kidney function test
  • Ventricular assist devices

ASJC Scopus subject areas

  • Nephrology
  • Hematology


Dive into the research topics of 'Effect of percutaneous ventricular assist devices on renal function'. Together they form a unique fingerprint.

Cite this